Vascular Brachytherapy: A New Approach to Renal Artery In-Stent Restenosis

Journal of Invasive Cardiology

Volumn 16, Issue 4, 2004, Pages 224-228

  Jahraus, Christopher D ^a   Meigooni, Ali S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Angioplasty; Endovascular; Radiotherapy; Renal artery stenosis; Stent; Vascular brachytherapy

Indexed keywords

ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BETA RADIATION; BRACHYTHERAPY; DOSIMETRY; GAMMA RADIATION; HUMAN; KIDNEY ARTERY STENOSIS; OSCILLATION; RADIATION DOSE; RENOVASCULAR HYPERTENSION; RESTENOSIS; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 1842528257     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Grüntzig A, Kuhlmann U, Vetter W, et al. Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet 1978;1:801-2.
2. Dorros G, Prince G, Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn 1993;29:191-8.
3. Blum U, Krumme B, Glugel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-65.
4. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: Characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314-23.
5. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: Where do we stand? A meta-analysis. Radiol 2000;216:78-85.
6. van de Ven PJG, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995;346:672-4.
7. Dorros G, Jaff M, Mathiak RN, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-7.
8. Bakker J, Goffette PP, Henry M, et al. The ERASME Study: A multicenter study on the safety and technical results of the Palmaz Stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol 1999;22:468-74.
9. Shammas NW, Kapalis MJ, Dippel EJ, et al. Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol 2004;16:10-3.
10. Reilly JP, Kaminski J, Summers JB. The three R's: Radiation for restenotic renals? South Med J 2003;96:1094-5.
11. Bax L, Mali W, van de Ven P, et al. Repeated intervention for in-stent restenosis of renal arteries. J Vasc Interv Radiol 2002;13:1219-24.
12. Munneke GJ, Engelke C, Morgan RA, Belli AM. Cutting balloon angioplasty for resistant renal artery in-stent restenosis. J Vasc Interv Radiol 2002;13:327-31.
13. Rao BH, Chandra KS. Renal artery in-stent restenosis: Treatment with high speed rotational atherectomy. Indian Heart J 2000;52:205-6.
14. Tanigawa N, Sawada S, Kobyayashi M. Reaction of the aortic wall to six metallic stent materials. Acad Radiol 1995;2:379-84.
15. Zeller T, Müller C, Frank U, et al. Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Catheter Cardiovasc Interv 2003;60:1-6.
16. Schmidt E, Grutzmacher P, Meyer T, et al. Einfluss von verapamil auf die restenosierungsrate nach transluminaler angioplastie von nierenarterienstenosen. Z Kardiol 1990;79:441-5.
17. Sheppard R, Eisenberg MJ. Intracoronary radiotherapy for restenosis. N Engl J Med 2001;344:295-7.
18. Sapirstein W, Zuckerman B, Dillard J. FDA approval of coronary-artery brachytherapy. N Engl J Med 2001;344:297-9.
19. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
20. King SB, Williams DO, Chougule P, et al. Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty: Results of the beta energy restenosis trial (BERT). Circulation 1998;97:2025-30.
21. 90Y β-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-6.
22. Crocker I. Considerations on radiation source selection and utilization in vascular brachytherapy. J Invasive Cardiol 2003;15:664-8.
23. Amols HI, Zaider M, Weinberger J, et al. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int J Radiat Oncol Biol Phys 1996;36:913-21.
24. Sehgal V, Li Z, Palta JR, Bolch WE. Dosimetric effect of source centering and residual plaque for β-emitting catheter based intravascular brachytherapy sources. Med Phys 2001;28:2162-71.
25. Jahraus CD, St. Clair W, Gurley J, Meigooni AS. Endovascular brachytherapy for the treatment of renal artery in-stent restenosis using a β-emitting source: A report of five patients. South Med J 2003;96:1165-8.
26. Chrysant GS, Goldstein JA, Casserly IP, et al. Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis. Cathet Cardiovasc Intervent 2003;59:251-4.
27. Aslam MS, Balasubramanian J, Greenspahn BR. Brachytherapy for renal artery instent restenosis. Cathet Cardiovasc Intervent 2003;58:151-4.
28. Kotzerke J, Gabelmann A, Hanke H. Rezidivierende nierenarterienstenose - endovaskuläre brachytherapie mit einem rhenium-188-gefüllten ballonkatheter. Rofo Fortschr Geb Rontgenstr N 2002;174:1176-8.
29. Stoeteknuel-Friedli S, Do DD, von Briel C, et al. Endovascular brachytherapy for prevention of recurrent renal in-stent restenosis. J Endovasc Ther 2002;9:350-3.
30. Anonymous. Use of gamma radiation for treatment of renal artery in-stent restenosis. Cardiovascul Radiat Med 2001;2:197-8.
31. Stückle CA, Laufer U, Kirchner J, et al. Successful treatment of intimal hyperplasia in renal arteries by endovascular brachytherapy. Cardiovascul Radiat Med 2001;2:114-8.
32. Grube E, Silber S, Hauptmann KE, et al. Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42.
33. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-7.